Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow impairment and lung inflammation. Inhaled corticosteroids (ICs) are prescribed for up to 50% of patients with COPD, although no beneficial effect has been demonstrated. ICs have fewer side effects than oral corticosteroids, but they can cause systemic …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have